Autopsy report · NCT04406948

Study of Safety and Efficacy of MGCND00EP1 as an Add on Treatment in Children and Adolescents With Resistant Epilepsies

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.

“Failure to overcome bureaucratic obstacles within timeframe.”

The sponsor’s own words in the registry.

Life of this trial

Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status: Withdrawn
Phase: Phase 2
Sponsor: MGC Pharmaceuticals d.o.o
Sponsor type: Industry
Conditions: Resistant Epilepsy, Drug; Adolescent Epilepsy; Children Epilepsy; Children and Adolescents With Resistant Epilepsies
Interventions: MGCND00EP1; Placebo; ECG; EEG; Blood and urine collection
Participants: 0
Sites: 2
Countries: Israel, Slovenia

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.